Procter & Gamble Health Limited: Detailed financials

Line items extracted directly from the company's NSE-filed XBRL. Click + to expand subtotals. Click any row to chart it. All values in ₹ crore.

Particulars	Sep-24	Dec-24	Mar-25	Jun-25	Sep-25	Dec-25	Mar-26	Jun-26
Revenue	313	310	311	339	325	374	370	364
Other income	3	4	3	4	5	4	4	4
Expenses	205	192	236	254	211	269	241	270
Cost of materials consumed	48	62	91	60	78	85	85	80
Purchases of stock-in-trade	20	13	14	24	11	13	22	25
Change in inventories	20	0.80	-6	10	-20	12	-15	-9
Employee benefit expense	46	47	49	56	54	62	51	60
Finance costs	0.10	0.10	0.10	0.10	0.10	0.10	0.20	0.10
Depreciation & amortisation	6	6	5	5	6	6	6	6
Other expenses	65	64	83	98	82	92	91	108
EBITDA	117	128	84	94	125	115	139	135
EBIT	111	122	79	89	119	109	133	129
Exceptional items	-	-	-	-	-	-	-	32
Profit Before Tax	111	122	79	89	119	109	133	129
Tax expense	29	31	17	23	31	31	39	33
Deferred tax	1	2	-3	-0.30	-0.10	-2	7	2
Net Profit	82	91	61	66	89	78	95	96
Financial Ratios
Operating Profit Margin	35.50%	39.39%	25.27%	26.22%	36.65%	29.17%	36.00%	35.47%
EBITDA Margin	37.35%	41.16%	27.01%	27.82%	38.52%	30.75%	37.68%	37.12%
Net Profit Margin	26.29%	29.32%	19.68%	19.53%	27.23%	20.75%	25.57%	26.43%
Earnings Per Share (₹)	49.60	54.76	36.86	39.87	53.34	46.74	56.99	57.92

Revenue

₹ in crore

Click any row in the table to chart it here.

Source: NSE integrated filing results & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Ratios (operating margin, net margin) and EBITDA / EBIT / FCF / shareholders' funds are computed from the filed line items.